Shanghai Haohai Biological Technology Co., Ltd. (FRA:5HB)

Germany · Delayed Price · Currency is EUR

1.740

-0.030 (-1.69%)

Last updated: Jun 24, 2026, 5:15 PM CET

-34.09% (1Y)

Market Cap	831.31M -37.4%
Revenue (ttm)	301.68M -9.5%
Net Income	29.46M -43.3%
EPS	0.13 -42.9%
Shares Out	n/a
PE Ratio	28.22
Forward PE	n/a
Dividend	0.12 (7.12%)
Ex-Dividend Date	Jun 4, 2026

Volume	n/a
Open	1.750
Previous Close	1.770
Day's Range	1.740 - 1.750
52-Week Range	1.710 - 3.240
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 24, 2026

About FRA:5HB

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, Europe, the United States, and internationally. The company offers ophthalmic implants, assistive devices, and medical devices; medical optical instruments, including intraocular lenses, endoscopic equipment, ophthalmic surgical instruments, and other ophthalmic medical products; hyaluronic acid and chitosan; and electronic instruments, such as semiconductors, optoelectronics, lasers, radio frequ... [Read more]

Industry Pharmaceutical Preparations

Founded 2007

Employees 2,110

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 5HB

Financial Performance

In 2025, FRA:5HB's revenue was 2.45 billion, a decrease of -8.71% compared to the previous year's 2.68 billion. Earnings were 251.01 million, a decrease of -40.30%.

Financial numbers in CNY Financial Statements